Table 1.
S.No. | Hallmarks of Cancer | Regulated gene/Pathways |
---|---|---|
1 | Uncontrolled Proliferation Signalling | Regulates E2F pathways Regulates PI3K/Akt/mTOR pathway Regulates Ras/Raf/MEK/ERK pathway Regulates MAPK pathway |
2 | Evading Growth Suppressors and cell cycle checkpoints | Inhibits RB (gatekeeper protein) pathway Inhibits p53 (tumour suppressor protein) pathway |
3 | Resisting cell death | Inhibits BAX and CASP7-mediated apoptosis Inhibit Fas-mediated apoptosis pathway Proliferation of E2F target genes |
4 | Enabling replicative immortality | Activation of telomere maintenance mechanism Loss of RB checkpoints Loss of p53 function |
5 | Inducing angiogenesis | Activate pro-angiogenic genes such as VEGF-A, FDGF-B, IL-8, CXCL-2 |
6 | Activating invasion and metastasis | Regulates SNAI1, LEF1 and TWIST1 to repress CDH1 gene (E-cadherin) Regulate TGF-β, Wnt pathway proteins and Notch 3 receptor |
7 | Deregulating energy metabolism | Regulating PI3K/Akt/mTOR, Myc, PKM2, RB/E2F1 and p53 pathway |
8 | Evading immune dystruction | Regulation of gene encoding MHC Class II and Fas Regulation of TGF-β pathway |
9 | Tumour promoting inflammation | Regulates expression of mTOR, STAT3, MMP-2, CD44, CCL5 AND CCL2 |